SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Safran S.A. (SAFRY) trades at a trailing P/E of 22.7, forward P/E of 37.2. Trailing earnings yield is 4.41%, forward earnings yield 2.69%. PEG 2.89.
Criteria proven by this page:
- VALUE (75/100, Pass) — P/E is below market average (22.7); earnings yield beats bond yields (4.41%).
- PEG Ratio 2.89 — above 2.0 suggests expensive relative to earnings growth.
- Trailing Earnings Yield 4.41% — roughly competitive with bond yields (~4.3%), moderate risk-reward.
Overall SharesGrow Score: 64/100 with 3/7 criteria passed.
SharesGrow 7-Criteria Score
✓
VALUE
75/100
Price-to-Earnings & upside
Proven by this page
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — SAFRY
Valuation Multiples
P/E (TTM)22.7
Forward P/E37.2
PEG Ratio2.89
Forward PEG2.89
P/B Ratio0.00
P/S Ratio5.23
EV/EBITDA0.0
Per Share Data
EPS (TTM)$4.13
Forward EPS (Est.)$2.52
Book Value / Share$0.00
Revenue / Share$17.92
FCF / Share$0.00
Yields & Fair Value
Earnings Yield4.41%
Forward Earnings Yield2.69%
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$1.08 |
$16.62B |
$1.91B |
11.5% |
| 2017 |
$2.23 |
$16.52B |
$4.55B |
27.5% |
| 2018 |
$0.74 |
$21.18B |
$1.28B |
6.1% |
| 2019 |
$1.41 |
$25.1B |
$2.45B |
9.7% |
| 2020 |
$0.20 |
$16.63B |
$352M |
2.1% |
| 2021 |
$0.02 |
$15.13B |
$43M |
0.3% |
| 2022 |
$-1.44 |
$19.52B |
$-2.46B |
-12.6% |
| 2023 |
$2.00 |
$23.65B |
$3.44B |
14.6% |
| 2024 |
$-0.38 |
$27.72B |
$-667M |
-2.4% |
| 2025 |
$4.13 |
$29.96B |
$6.89B |
23% |
